USPTO serial 79053605
WISTALAB
Reviewed by CopyMark Law Group
Reg. 3749892Status 404
- Filing date
- Status date
- Registration date
- Feb 16, 2010
- Examiner
- WIENER, MICHAEL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with WISTALAB?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Grant A. Monachino
Grant A. Monachino Baker & Hostetler LLP1900 East 9th Street #3200Cleveland, OH 44114UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of diseases, illnesses and ailments in humans and animals, namely, infectious and parasitic diseases, neoplasms, blood disorders, mental disorders, disorders of the nervous system and sensory, organs, musculoskeletal system disorders, genitourinary system disorders, communicable diseases, neurological diseases, and psychological conditions; chemical preparations for medical and pharmaceutical purposes, namely, for the treatment of diseases, illnesses and ailments in humans and animals, namely, infectious and parasitic diseases, neoplasms, blood disorders, mental disorders, disorders of the nervous system and sensory, organs, musculoskeletal system disorders, genitourinary system disorders, communicable diseases, neurological diseases, and psychological conditions; first aid kits and diagnostic kits comprised of pharmaceutical and chemical preparations for the treatment of diseases, illnesses, and ailments in humans and animals, namely, infectious and parasitic diseases, neoplasms, blood disorders, mental disorders, disorders of the nervous system and sensory, organs, musculoskeletal system disorders, genitourinary system disorders, communicable diseases, neurological diseases, and psychological conditions | SECTION 71 - CANCELLED | — |
| 009 | Computer software for facilitating research in the fields of science, medicines, drugs, pharmaceuticals, biology, biotechnology, bioinformatics, clinical development and statistics, laboratory and diagnostic instruments, namely, computer software for use in the analysis and diagnosis of medical conditions; pre-recorded CD-ROMS and computer disks containing electronic publications, namely, test reports, magazines and manuals, and information in the fields of pre-clinical, clinical and pharmaceutical research and drug discovery and drug research; computer servers for scientific, medical, drug, clinical, pharmaceutical, biological, biotechnical, bioinformatic and statistical research; pre-recorded magnetic data carriers and pre-recorded computer disks containing databases and information in the field of scientific, medical, drug, clinical, pharmaceutical, biological, biotechnical, bioinformatic and statistical research | SECTION 71 - CANCELLED | — |
| 010 | Medical apparatus and instruments for facilitating the analysis of biological and chemical matter in the field of genetic testing, namely, blood, brain, urine, cerebrospinal fluid (csf) analysis and testing apparatus; medical apparatus for introducing pharmaceutical preparations into the body, the foregoing for carrying out tests for genetic testing; medical testing apparatus for the analysis of biological and chemical matter, namely, apparatus for blood, brain, urine and cerebrospinal fluid (csf) analysis and tests; surgical and medical apparatus and instruments for facilitating the analysis of biological and chemical matter, namely, apparatus for blood, brain, urine and cerebrospinal fluid (csf) analysis and tests | SECTION 71 - CANCELLED | — |
| 016 | Printed matter, namely, almanacs, booklets, books, catalogues, hand books, journals, manuals, magazines, periodicals, newspapers, pamphlets and prospectuses, all in the fields of biology, biotechnology, drugs, medicines, chemical preparations, pharmaceuticals, bioinformatics and scientific design, development and research and medical laboratory research | SECTION 71 - CANCELLED | — |
| 035 | Retail store services featuring pharmaceutical and medical preparations, chemical preparations for medical and pharmaceutical purposes, scientific, measuring and teaching apparatus and instruments, computer software, surgical and medical apparatus and instruments, apparatus for carrying out tests for medical purposes, scientific and medical apparatus for use in tests, and printed matter, books, journals, magazines, leaflets, publications, printed tests, written reports in the field of medical and pharmaceutical research | SECTION 71 - CANCELLED | — |
| 042 | Medical, pharmaceutical, genetic, biological and biotechnology research; design, research and development of drugs, pharmaceuticals and medicines for others; laboratory and medical laboratory research and development of drugs, pharmaceuticals and medicines for others; scientific development research and consultation in the fields of synthetic chemistry, organic chemistry, medicinal chemistry, pharmacological chemistry, anorgic chemistry, analytical chemistry, biological chemistry, radiochemistry, data analysis, informatics, bio-informatics, chem-informatics, computer aided design, artificial intelligence, neural networks, statistics, mathematics, physics and biophysics; biological development research and consultation in the fields of anatomy, pharmacology, pharmacokinetics, physiology, pathophysiology, aetiology, genomics, genetics, biochemicals, toxicology, neurochemistry, cellular biology, molecular biology, proteomics, pharmacological genetics and metabonomics; scientific research and development services for clinical development in the fields of drug development, clinical trial design, patient recruitment, drug testing, clinical data management, data analysis, statistical analysis, patient selection, clinical diagnosis and diagnostic testing; preparation of reports of scientific and medical research concerning medicines, pharmaceuticals, genetics, biology, biotechnology and drugs; development of prognostic and diagnostic tools for others; providing research consultation and information in the fields of medical, pharmaceutical, genetic, biological, drug, clinical, statistical and biotechnological research | SECTION 71 - CANCELLED | — |
| 044 | Medical services featuring health assessment surveys; providing information and consultancy relating to the aforesaid medical services | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by WisTa Laboratories Ltd
- Other trademarks owned by WisTa Laboratories Ltd
- Other trademarks owned by WisTa Laboratories Ltd
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 016
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named WISTALAB
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 6, 2018 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Jul 6, 2018 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jun 30, 2017 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jun 13, 2017 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jun 13, 2017 | INPC | INVALIDATION PROCESSED | — |
| May 23, 2017 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Sep 23, 2016 | C71T | CANCELLED SECTION 71 | — |
| Sep 10, 2015 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 26, 2015 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Feb 5, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 9, 2010 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 9, 2010 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 16, 2010 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 16, 2010 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 1, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 30, 2009 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Nov 12, 2009 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 12, 2009 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Nov 11, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| Nov 10, 2009 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 10, 2009 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 27, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 27, 2009 | ALIE | ASSIGNED TO LIE | — |
| Oct 15, 2009 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Oct 14, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 14, 2009 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 14, 2009 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 2, 2009 | MREI | NOTICE OF REINSTATEMENT MAILED | — |
| Sep 30, 2009 | RGIA | REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED | — |
| Aug 18, 2009 | MAB0 | ABANDONMENT NOTICE MAILED - INCOMPLETE RESPONSE | — |
| Aug 17, 2009 | ABN0 | ABANDONMENT - INCOMPLETE RESPONSE | — |
| Jul 29, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 29, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 28, 2009 | ALIE | ASSIGNED TO LIE | — |
| Jul 24, 2009 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jan 30, 2009 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 29, 2009 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 9, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 9, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 9, 2009 | ALIE | ASSIGNED TO LIE | — |
| Dec 30, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 18, 2008 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 1, 2008 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 1, 2008 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 1, 2008 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 30, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 13, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 13, 2008 | NWAP | NEW APPLICATION ENTERED | — |
| Jun 12, 2008 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |